Radiosyntheses and reactivities of novel [18F]2‐fluoroethyl arylsulfonates
- 25 July 2005
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 48 (10) , 735-747
Abstract
[18F]2‐Fluoroethyl tosylate ([18F]FEOX, X=Ts) is widely used for labeling radiotracers for positron emission tomography (PET). Little work has been reported on syntheses of other [18F]2‐fluoroethyl arylsulfonates ([18F]FEOX) that bear a less electron‐rich aryl group, even though these might offer enhanced reactivities. Thus, a series of novel [18F]FEOX (X=benzenesulfonyl, brosyl, nosyl, 3,4‐dibromobenzenesulfonyl) were synthesized and reactivities compared to [18F]FEOTs. Precursors for radiolabeling (bis‐ethylene glycol arylsulfonates) and reference FEOX were synthesized (alcohol+arylsulfonyl chloride+KOSiMe3 in THF). Regardless of substitution pattern, [18F]FEOX (110°C, 5 min, acetonitrile) were obtained in similar decay‐corrected isolated radiochemical yields (RCY; 47–53%). All [18F]FEOX gave excellent RCYs (64–87%) of the dopamine uptake radioligand, [18F]FECNT (130°C, 10 min, acetonitrile). The 3,4‐dibromobenzensulfonate gave the highest RCY of [18F]FECNT (87%) and this HPLC‐purified labeling agent was used directly for efficient [18F]FECNT production. When the secondary aniline of an amyloid probe (HM‐IMPY) or p‐nitrophenol was reacted with [18F]FEOX, RCYs were appreciably higher for brosylate and nosylate than for tosylate, while 3,4‐dibromobenzenesulfonate again gave the highest RCY. Owing to the high reactivity of the new [18F]FEOX and their ease of syntheses via stable precursors, such agents (particularly 3,4‐dibromobenzenesulfonate) should be considered as alternatives to [18F]FEOTs. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 10 references indexed in Scilit:
- Development of a New Radioligand, N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for PET Imaging of Peripheral Benzodiazepine Receptor in Primate BrainJournal of Medicinal Chemistry, 2004
- Synthesis and Evaluation of Two 18F-Labeled 6-Iodo-2-(4‘-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine Derivatives as Prospective Radioligands for β-Amyloid in Alzheimer's DiseaseJournal of Medicinal Chemistry, 2004
- Efficient O‐ and N‐(β‐fluoroethylation)s with NCA [18F]β‐fluoroethyl tosylate under microwave‐enhanced conditionsJournal of Labelled Compounds and Radiopharmaceuticals, 2004
- Efficient alkali iodide promoted 18F-fluoroethylations with 2-[18F]fluoroethyl tosylate and 1-bromo-2-[18F]fluoroethaneTetrahedron Letters, 2003
- 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transportersNuclear Medicine and Biology, 2000
- Solid phase extraction—an alternative to the use of rotary evaporators for solvent removal in the rapid formulation of PET radiopharmaceuticalsJournal of Labelled Compounds and Radiopharmaceuticals, 1999
- Synthesis of two radiofluorinated cocaine analogues using distilled 2-[18F]fluoroethyl bromideApplied Radiation and Isotopes, 1995
- N.C.A. 18F‐fluoroalkylation of H‐acidic compoundsJournal of Labelled Compounds and Radiopharmaceuticals, 1988
- The N.C.A. nucleophilic 18F‐fluorination of 1,N‐disubstituted alkanes as fluoroalkylation agentsJournal of Labelled Compounds and Radiopharmaceuticals, 1987
- Potentielle Reaktivatoren der Acetylcholinesterase 2. Mitt.: Bisquartäre N‐Alkoxypyridinium‐carbaldoximeArchiv der Pharmazie, 1969